Portfolio company
Genomind
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops pharmacogenetic tests and decision support software to help healthcare providers and patients personalise medication selection based on individual genetic profiles.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
OneOme
This company provides pharmacogenomic testing and clinical software to help healthcare organisations and providers tailor medication decisions to a patient's genetic profile.
CNSDose
This company provides genetic testing kits to help healthcare providers and patients select antidepressants and other medications based on individual cheek swab results.
Circular Genomics
This company develops circular RNA blood tests for diagnosing neurological and psychiatric disorders for healthcare providers, researchers and pharmaceutical organisations.
Genoox
This company develops a cloud-based genomic data analysis platform for clinicians, genetic counsellors, and healthcare organisations to interpret genetic variants and improve patient care.
PointHealth
This company develops an artificial intelligence platform providing clinical decision support to help behavioural health providers select suitable medications for patients.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Sano Genetics
This company provides a software platform connecting patients with chronic conditions to pharmaceutical researchers for precision medicine clinical trials and genetic testing.
Evogenom
This company provides at-home genetic testing kits and an AI-powered mobile application that offers personalised wellness and nutrition insights for health-conscious consumers.
